Navigation Links
VIDEO from Medialink and AAFA: Asthma PSA Reinforces Prevention of Asthma Symptoms

NEW YORK, Feb. 16 /PRNewswire/ -- The Asthma and Allergy Foundation of America (AAFA) is launching a national public service announcement (PSA) supported by GlaxoSmithKline titled "Two Main Causes of Asthma." The PSA goal is to communicate an important message to the millions of Americans with asthma: that treating the two main causes of asthma symptoms may help prevent symptoms before they begin.  Asthma symptoms include coughing, wheezing, difficulty breathing and chest tightness.  

See video from AAFA at:

"This simple message is a largely misunderstood aspect of asthma," said William McLin, AAFA President & CEO.  "While 20 million Americans know that asthma can slow them down, they may not know that there are two main causes – airway constriction they feel, and inflammation they may not feel – and that most asthma medicines only treat one cause."

The PSA features two cyclists riding on a tandem bicycle representative of the two main causes of asthma symptoms. When the lead cyclist pedals solo she struggles but when the second cyclist begins to peddle, the journey becomes much easier. Their ride together is symbolic of managing asthma more effectively by treating both main causes of asthma symptoms when one medicine is not enough to prevent symptoms.  

The PSA encourages the millions of people suffering from asthma to find information and resources about asthma and learn how to work with their doctor to help prevent asthma symptoms at

According to AAFA, every day in America because of asthma, 60,000 people miss school or work, 30,000 have an attack, 5,000 visit the emergency room and 1,000 get admitted to the hospital. Asthma in America isn't merely a problem but it's nearly an epidemic.

"At AAFA, our mission is to help people with asthma live a "Life Without Limits," added McLin.  "This is possible, but only when people are educated about asthma symptoms and how to prevent symptoms. That is how a national public service announcement can help."

About AAFA

The Asthma and Allergy Foundation of America (AAFA) is the leading national nonprofit organization fighting asthma and allergic diseases. AAFA provides free information, conducts educational programs, fights for patients' rights, and funds research to find better treatments and cures. Log on to for more information.

Funding and editorial support for the PSA was provided by GlaxoSmithKline.

Medialink is a division of The NewsMarket.  Registered journalists can access video, audio, text, graphics and photos at


SOURCE Medialink; AAFA



SOURCE Medialink; AAFA
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Video: Nutrition Comes to NASCAR
2. Research Links TV/Video Game Playing With Child Obesity; Health Experts Back a New Approach
3. Launches Video Contest for Young Directors
4. Video: Circulatory Care of New Jersey
6. VIDEO from Medialink and General Motors: On and Off the Track
7. TriWest and Montana VA Launch PTSD Video Conference to Reach Rural Health Care Providers
8. Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region
9. VIDEO from Medialink and Siemens: The Next Generation Allergy Test - Nothing to Sneeze At
10. Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nations Preparedness for Disasters
11. VIDEO from Medialink and General Mills: Digestive Health
Post Your Comments:
(Date:12/1/2015)... NY (PRWEB) , ... December 01, 2015 , ... ... non-traumatic limb amputations in the United States. Podiatrists are well aware that psychology-based ... adopt therapeutic behaviors) are often catastrophic contributors to diseases of the diabetic foot. ...
(Date:12/1/2015)... ... December 01, 2015 , ... For the ... is why Hollister Incorporated has launched the VaPro Plus Pocket™ touch free hydrophilic ... the VaPro touch free catheter portfolio,” said Michael Gresavage, Vice President North America. ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next IT Healthcare, the leader ... in this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the ... finalist in the category of Digital Solutions for its innovative, industry-leading product, Alme ...
(Date:12/1/2015)... ... 2015 , ... TCS Healthcare Technologies (TCS), a leading provider ... is pleased to announce that VIP Care Services, a Caprock Health Group affiliate ... Complete Care™ Management to back their collaborative catastrophic case management initiatives. ACUITY Complete ...
(Date:12/1/2015)... GA (PRWEB) , ... December 01, 2015 , ... ... supports SACC-GA and SACC-USA through membership and leadership since 2008. Gary ... Chair for SACC-USA . Gary has spent a significant amount of time ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... BOSTON , December 1, 2015 Russia ... phase III clinical trials. 70% of new drugs registered in ... trials in Russia . --> Russia has ... trials. 70% of new drugs registered in Europe ... . --> Russia has always been ...
(Date:12/1/2015)... , Dec. 1, 2015 Relmada Therapeutics, Inc. ... treatment of chronic pain, announced today that the company will ... be held December 1-3 at the Luxe Sunset Boulevard Hotel ... Traversa , CEO of Relmada Therapeutics, will present on Thursday, ... Time). . Please register at least 10 ...
(Date:12/1/2015)...   MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), ... filed an Investigational New Drug Application (IND) with the ... lead fully human antibody product HuMab 5B1 as a ... initiate the Phase I clinical trial early in 2016. ... The planned Phase I trial will evaluate the safety, ...
Breaking Medicine Technology: